Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

755
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
755
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.0K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

541
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
541
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

632
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
632

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway.

Hepatology international·2023
Same author

Correction to "Improved Antiviral Activity of Classical Swine Fever Virus-Targeted siRNA by Tetrahedral Framework Nucleic Acid-Enhanced Delivery".

ACS applied materials & interfaces·2023
Same author

Synergistic Photochemo Effects Based on Light-Activatable Dual Prodrug Nanoparticles for Effective Cancer Therapy.

Advanced healthcare materials·2023
Same author

PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism.

Cancer research·2023
Same author

A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Journal of translational medicine·2022
Same author

Sorafenib-Loaded Cu<sub>2-x</sub>Se Nanoparticles Boost Photothermal-Synergistic Targeted Therapy against Hepatocellular Carcinoma.

Nanomaterials (Basel, Switzerland)·2022

Related Experiment Video

Updated: Feb 6, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.4K

Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions.

Chen Wu1, Zhi-Ping Jin2, Shu-Qiang Weng1

  • 1Department of Gastroenterology and Hepatology and Shanghai Institute of Liver Diseases Zhongshan Hospital Fudan University Shanghai China.

Medcomm
|February 5, 2026
PubMed
Summary

Stem cell therapies offer new hope for inflammatory diseases, with targeted delivery showing the most promise for localized conditions. Minimally processed cell therapies also show potential, though further research is needed for widespread application.

Keywords:
hematopoietic stem cellhematopoietic stem cell transplantationinduced pluripotent stem cellinflammatory bowel diseaseinflammatory diseasemesenchymal stem cell

More Related Videos

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

696
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K

Related Experiment Videos

Last Updated: Feb 6, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.4K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

696
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K

Area of Science:

  • Regenerative Medicine
  • Immunology
  • Gastroenterology

Background:

  • Inflammatory diseases like IBD and RA pose significant challenges, with many patients unresponsive to current biologic therapies.
  • Stem cell therapeutics offer a regenerative approach to address the complex, multifactorial nature of these conditions.
  • Existing treatments often fail to fully restore tissue function or address underlying disease mechanisms.

Purpose of the Study:

  • To compare the clinical efficacy of various stem cell strategies for inflammatory diseases.
  • To analyze the impact of different cell sources and delivery methods on therapeutic outcomes.
  • To identify key barriers and propose solutions for advancing stem cell therapy in this field.

Main Methods:

  • Systematic review and analysis of clinical outcomes from diverse stem cell interventions.
  • Comparative assessment of cell sources, including autologous and potentially allogeneic options.
  • Evaluation of delivery methodologies, focusing on targeted versus systemic approaches.

Main Results:

  • Targeted delivery systems demonstrated superior efficacy in managing localized inflammatory lesions and promoting tissue restoration.
  • Minimally processed cellular interventions, such as autologous fat grafting and stromal vascular fraction, exhibited significant therapeutic promise.
  • Challenges remain, including suboptimal cell homing, limited engraftment, and incomplete long-term safety data.

Conclusions:

  • Optimizing stem cell therapeutics requires addressing translational barriers like cell homing and engraftment.
  • Advanced strategies, including induced pluripotent stem cells and genetic modification, are crucial for future development.
  • This review provides a framework for evidence-based stem cell application in refractory inflammatory diseases, paving the way for personalized regenerative medicine.